Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma

NCT00091676 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

629

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkins Lymphoma

Interventions

BIOLOGICAL: FNHLId1
BIOLOGICAL: KLH + GM-CSF

Sponsor

Biovest International